Behavioral Finance | Multibagger Shares

May 18, 2026

Hero banner with title 'Vigil Mechanism & Whistleblower Policy Disclosures' and a green FY21–FY25 timeline on dark blue background, conveying process milestones.

Vigil Mechanism & Whistleblower Policy Disclosures: SEBI LODR Regulation 22 and Companies Act §177(9)

How to read the Vigil Mechanism / Whistleblower Policy section of an Indian Annual Report — the three overlapping laws, the five-component checklist, and what Titan Biotech FY25's governance markers illustrate. Educational only — not a buy/sell call.

May 17, 2026

Infographic with four colored blocks labeled: Lucky (gray), Disciplined Investor (green), Confused (light gray), Bias-Trapped (orange).

The Ostrich Effect: Karlsson, Loewenstein & Seppi’s 2009 NBER Bias Behind Why Indian Investors Stop Checking Their Portfolios During Corrections

The Ostrich Effect — documented by Karlsson, Loewenstein & Seppi in 2009 — explains why Indian investors stop checking portfolios during market corrections. Brokerage logins fall 9.5% on down-1% days. We walk through the academic foundation, Indian SIP-discontinuation and demat-dormancy data, a seven-step counter-measure checklist, and Titan Biotech's FY25 disclosure architecture as an illustrative anti-ostrich case study.

May 17, 2026

Hero image: dark blue page with white 'Board Meeting Frequency' title, green subtitle, and a green timeline across FY21–FY25 showing milestones: Compliance, Disclosure, Audit clean, Board change, All boxes.

Board Meeting Frequency: SEBI LODR Regulation 17(2) and the Forensic Governance Engagement Test

Board meeting frequency is the cheapest forensic governance signal hidden in every Indian annual report. SEBI LODR Reg 17(2) sets the floor at 4, best-practice boards meet 8-12 times, and Titan Biotech FY25 illustrates the disciplined end with 14 meetings sitting alongside a fortress balance sheet.

May 16, 2026

Infographic-style hero showing four investor mindsets: Lucky (left, gray), Confused (left, light gray), Disciplined Investor (right, green), and Bias-Trapped (right, orange).

Myopic Loss Aversion (Benartzi & Thaler 1995): Why Indian Retail Investors Sabotage Long-Term Returns by Checking Portfolios Too Often

Myopic Loss Aversion — Benartzi & Thaler's 1995 Nobel-grade explanation of the equity premium puzzle, applied to Indian retail investors, with Titan Biotech FY25 audited numbers as an anti-MLA corporate-cadence case study.